Viewing StudyNCT06488716



Ignite Creation Date: 2024-07-17 @ 10:42 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06488716
Status: RECRUITING
Last Update Posted: 2024-07-05
First Post: 2024-06-20

Brief Title: A Study to Evaluate the Safety Pharmacokinetics and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor: Genentech Inc
Organization: Genentech Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08-15
Start Date Type: ESTIMATED
Primary Completion Date: 2027-02-28
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-02-28
Completion Date Type: ESTIMATED
First Submit Date: 2024-06-20
First Submit QC Date: None
Study First Post Date: 2024-07-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-17
Last Update Post Date: 2024-07-05
Last Update Post Date Type: ACTUAL